M2R
0.003
50%
CNJ
0.02
-73.7%
RAD
0.026
44.4%
NAE
0.002
-33.3%
MEM
0.004
33.3%
SPX
0.002
-33.3%
VKA
0.009
28.6%
RKB
0.003
-25%
RDN
0.005
25%
TAR
0.018
-25%
DRO
2.83
23%
OEL
0.004
-20%
NFM
0.017
21.4%
TDO
0.14
-17.6%
4DX
2.95
20.9%
BMO
0.033
-15.4%
VAR
0.006
20%
AX8
0.006
-14.3%
PTX
0.11
18.3%
BNL
0.006
-14.3%
BLU
0.007
16.7%
ECS
0.006
-14.3%
GLL
0.007
16.7%
ENV
0.006
-14.3%
MGL
0.245
16.7%
SER
0.006
-14.3%
VSR
0.035
16.7%
AZY
0.537
-13.4%
EOS
7.44
15.2%
ALM
0.007
-12.5%
BKB
0.8
15.1%
MML
0.028
-12.5%
SNX
0.031
14.8%
PL9
0.007
-12.5%
HPG
1.385
14.5%
SRJ
0.014
-12.5%
CLX
2.15
13.2%
GG1
0.185
-11.9%
MQR
0.009
12.5%
D3E
0.305
-11.6%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

The Stock Network

The Stock Network (TSN) is your trusted source for ASX stock market news, key trends, and investment insights. Stay tuned for the latest reports, expert market analysis, and IPO updates.

ASX & US stock news headlines

What is Disney doing with AI? Well we only need to look at their latest US $1 billion deal. The Walt Disney Company (NYSE:DIS) has just struck a three year licensing deal with OpenAI. Under the deal OpenAI’s Sora generative video platform will get to use over 200 Disney characters. These include Marvel, Pixar and Star Wars characters - meaning Disney will also become a key customer of OpenAI’s technology. This major deal between a legacy entertainment company and an AI firm could be a sign of things to come - who'll be next?

#finktok #stocks #entertainment #AI #tech
Shares in Electro Optic Systems Holdings (ASX:EOS) have bounced after landing a major AUD $120 million contract. The conditional contract is with a customer in the Republic of Korea and includes milestone payments. Under the deal EOS will supply its high energy laser product to its customer. This is the second export order for a 100kW class laser defence system, following the first export order to a Western European customer, announced in August 2025.

#finktok #stocks #money #defence #tech
Brent Cook is a renowned exploration analyst and economic geologist with more than 40 years of experience in mineral exploration, mining and related financial sectors, having worked in over 60 countries and in virtually all geological environments. Brent has been and remains a highly respected consultant to various funds, major mining companies and junior explorers.

Brent Cook joins Lel Smits from The Stock Network to discuss how shifting exploration appetite among major miners may shape the next phase of the commodity cycle and how he is seeing the resource market, particularly from a North American perspective.

🌍 Track record working in more than 60 countries
📈 Mining cycle outlook and why majors are revisiting growth
🔎 Commodities to watch and emerging districts in 2026
⚒️ Role and relevance of prospect generator models
💼 Where Brent Cooper is investing time and capital
Western Australia–focused explorer and emerging gold producer Rumble Resources Limited (ASX:RTR) is accelerating development across its multi-commodity portfolio, underpinned by recent resource upgrades, a maiden tungsten resource and ongoing drilling designed to expand high-value assets. 

MST Access’ research note values Rumble Resources at A$0.23, significantly above the current A$0.038 share price, supported by a A$50m market cap and a strengthened cash position of A$4.99m plus A$3.9m pending from the raise. Key upcoming catalysts include drilling results, the final ore processing agreement, the tungsten production strategy, and project approvals expected through 1QCY26–1HCY26.

Joining The Stock Network’s Lel Smits, Managing Director and CEO Peter Harold outlines how Rumble is fast-tracking its Western Queen gold and tungsten project towards near-term production, advancing the globally significant zinc-lead-silver discovery, and leveraging a disciplined technical methodology.

⏳ Transitioning to near-term gold production
📊 Unlocking value across a multi-commodity portfolio
Most people think building wealth means finding the perfect portfolio. So they research, compare and wait for certainty.

The twist is perfect usually stops you from starting. There has never been a perfect portfolio, only one you will stick to. I have seen people delay investing for months while choosing between options that are almost identical.

The people who build real wealth pick something simple, automate it and let time do the work.

Perfect is a trap. Progress is the goal. A good plan you follow beats a perfect plan that never leaves your head. The market rewards participation, not perfection.

Brought to you by TSN education partner Josh Lee from Link Wealth Advice
___

General advice disclaimer: This post is general in nature and doesn’t take into account your individual circumstances or goals. Everyone’s situation is different. If you want advice that’s tailored to you, please get in touch so we can talk about what’s right for you.

#investing #wealthbuilding #financeaustralia #financialfreedom #longterminvesting #moneyhabits
Moonlight Resources has listed on the ASX with a ticker code of ML8. The company is a mineral explorer with a primary focus of defining a resource estimate at its flagship Clermont gold project in Queensland. The group is also advancing its MacDonnell Ranges project in the Northern Territory, where it has identified district-scale potential for rare earths and uranium mineralisation.
 
Media: The Stock Network, @lelsmits
Exultant Mining has listed on the ASX with a ticker code of 10X. The company is a mineral explorer focused on advancing its Peak View and Black Hammer gold, silver, copper, and base metals projects in the Lachlan Fold Belt of New South Wales. It also seeks to progress its Deep Dykes gold and lithium project in Western Australia, located along the Mt Ida -Ularring Greenstone Belt.
 
Media: The Stock Network, @lelsmits
Immutep Limited (ASX:IMM, NASDAQ:IMMP) has inked a deal to commercialise its oncology drug Eftilagimod Alfa (efti). The strategic collaboration is with India-based pharmaceutical group Dr. Reddy’s Laboratories (BSE:500124, NSE: DRREDDY, NYSE: RDY). Dr. Reddy’s will get exclusive rights to roll out efti across most global markets excluding North America, Europe, Japan and Greater China. In return, Immutep will receive an upfront USD $20 million (~AUD $30.2 million), also plus eligibility for up to USD $349.5 million (~AUD $528.4 million) in milestone payments, along with double-digit royalties. Efti is designed to activate the immune system to fight cancer, currently in Phase III trials for lung cancer and being tested across other tumour types

#health #stocks #money #fintok #biotech

ASX announcement news

4DX

14D

TMS

TEM

VR1

ALY

PE1

AVM

AQX

Sharing stock market news

European Lithium (ASX:EUR): Building a critical minerals portfolio through resource milestones

Vection Technologies (ASX:VR1, OTC:VCTNY, FRA:S1X): Accelerating APAC expansion

Listing on stock exchanges

Stock & market analysis.

FinTok

Stock & market analysis

IPOs

Listing on stock exchanges

Resources stocks & mining stocks

Noticeboard

ASX 200

Last Update: 17-12-2025
Today's Date: 2025-12-17
Market Status: Closed
Last Update: 17-12-2025

Top Gainers

M2R0.003 50%
RAD0.026 44.4%
MEM0.004 33.3%
VKA0.009 28.6%

Biggest Losers

CNJ0.02 -73.7%
NAE0.002 -33.3%
SPX0.002 -33.3%
RKB0.003 -25%

By proceeding, you can confirm you understand that we handle personal informational in accordance with our Privacy Policy